Project Grant HT94252410590
Award Date
7/1/24
Completion Date
6/30/26
Dollars Obligated
$622K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98195, USA
Similar Awards
The federal Project Grant award of $932,918 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is supporting research at the University of Washington to determine the role of somatic mosaicism in ovarian cancer predisposition. The grant, awarded on September 30, 2024 with an ultimate completion date of September 29, 2028, will enable the University of Washington to conduct innovative scientific studies to improve health outcomes for military...
This Project Grant award for $699,750 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to the University of Washington aims to support the discovery and characterization of tissue-specific regulatory mutations that predispose to ovarian cancer. The award will fund research activities over a 3-year period from April 2024 to March 2027. As a leading research university, the University of Washington has extensive experience managing federal grants and...
The University of Washington will receive $749,915 from the Defense Health Agency through September 2023 to August 2027 under the Military Medical Research and Development federal grant program (CFDA 12.420). The funding will support the university's project to enhance the efficacy of androgen receptor antagonist therapy with tumor necrosis factor-alpha blockade in metastatic prostate cancer. The Military Medical Research and Development program aims to transform military and public health...
The U.S. Defense Health Agency awarded a $1,965,204 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Washington to support the early-stage development of an anti-inflammatory melanocortin fusion protein for tactical combat casualty care. The award period runs from August 1, 2024 to July 31, 2027. This research aims to investigate new therapeutic approaches for improving health outcomes for military service members. As a prominent...
The University of Washington was awarded a $1,312,384 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from August 1, 2022 to July 31, 2025 to target FZD6 sensitization of advanced prostate cancer to genotoxic stress. Through this funding, researchers at the University of Washington aim to investigate medical solutions for prostate cancer by exploring how targeting...
The University of Washington was awarded a $1,166,250 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The three-year award will support long-read DNA sequencing and targeted RNA sequencing to identify previously undetectable classes of mutations in families with lethal prostate cancer. Through innovative biomedical research techniques, the project aims to transform healthcare for service...
The University of Washington received a $617,221 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant funds research to advance the efficacy, longevity, and safety of gene editing therapies for Duchenne muscular dystrophy (DMD). The 2-year grant period runs from August 15, 2023 to August 14, 2025. As a leading research institution, the University of Washington has previously received federal funding to support a...
The University of Washington was awarded a $1,137,371 project grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from January 2021 through January 2025 to rapidly test a novel therapeutic strategy for COVID-19 using human organoids and blood vessel structures. The Military Medical Research and Development program aims to transform health care for service members and the public...
This federal Project Grant award for $1,407,738.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is intended to support research focused on "ENHANCING IMMUNITY IN COLORECTAL CANCER LIVER METASTASES". The primary awardee is the University of Washington, a prominent research institution, which will collaborate with the Fred Hutchinson Cancer Center on this project. The research aims to investigate innovative approaches...
The University of Washington was awarded a $2.2 million project grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from January 2021 through January 2025 to rapidly test a novel therapeutic strategy for COVID-19 using human organoids and blood vessel structures. Through this funding, the University of Washington will investigate medical solutions for COVID-19 using...